Overview

Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
This is a randomized Phase III study to evaluate efficancy of weekly cisplatin or nedaplatin concurrent with Intensity-modulated radiation therapy in Nasopharyngeal Carcinoma (NPC).
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
He Xia
Treatments:
Cisplatin
Nedaplatin
Criteria
Inclusion Criteria:

- Pathologically confirmed untreated NPC patients

- T1-2N1-3M0 or T3-4NxM0

- 18-70 years old

- with MRI examinations

- ECOG ≤ 2

- With written consent

Exclusion Criteria:

- With a second cancer

- Pregnancy

- With other severe diseases (blood,liver ,kidney or heart diseases)

- Could not be staged properly

- Without written consent